Business Context and Reporting Period
This Form 8-K is a current report filed by Processa Pharmaceuticals, Inc. (PCSA) on March 14, 2023. The filing serves to disclose a regulatory event regarding the company's participation in the Oppenheimer 33rd Annual Healthcare Conference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a corporate event and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses solely on the announcement of a virtual investor presentation.
Guidance, Outlook, and Management Commentary
- Event: Processa Pharmaceuticals will present virtually at the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023, at 12:00 PM Eastern.
- Access: The presentation is furnished as Exhibit 99.1 and is available on the company's website under the "Investors" section.
- Forward-Looking Statements: The company undertakes no duty to update or revise the information contained in this report or the presentation, except as required by law or through other public disclosures.
- Regulation FD: The company notes it routinely uses its website to disclose material non-public information.
Investor Verification Checklist
- Verify the content of the presentation in Exhibit 99.1 for specific operational updates or clinical data not detailed in this summary.
- Confirm the company's current cash position and runway by reviewing the most recent 10-K or 10-Q filings, as this 8-K contains no financial data.
- Monitor the company's website for any subsequent press releases or updates regarding the conference presentation.